GENEVA – Swiss pharmaceutical giant Novartis said Wednesday its top lawyer is stepping down over a deal to hire U.S. President Donald Trump’s personal lawyer, Michael Cohen, as a consultant.
The company said general counsel Felix Ehrat is retiring “in the context of discussions surrounding Novartis’ former agreement with Essential Consultants, owned by Michael Cohen.”
FILE – This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. According to results published Sunday, Aug. 27, 2017, for the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, which has been the main focus for decades. Canakinumab’s maker, Novartis, sponsored the study. (Georgios Kefalas/Keystone via AP, File) “Although the contract was legally in order, it was an error,” Ehrat said in a statement, adding that he took “personal responsibility to bring the public debate on this matter to an end.”
Company spokesman Eric Althoff said last week Novartis had entered into a one-year agreement with Essential Consultants in February 2017 – a month after Trump’s inauguration – to focus on health care policy.
Althoff said Novartis, which is based in Basel, Switzerland, had hired Cohen for $100,000 per month, but determined after a single meeting with him that he wouldn’t be of use. The company still paid out the $1.2 million contract.
